Human Drugs View

Product Information
Registration Number DR-XY48073
Generic Name Azacitidine
Brand Name Xpreza
Dosage Strength 100mg
Dosage Form Lyophilized Powder for Injection (I.V./S.C.)
Classification Prescription Drug (Rx)
Pharmacologic Category Antineoplastic (Pyrimidine Analogue)
Packaging 50 mL-capacity clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white plastic flip-off cap (box of l’s)
Manufacturer Natco Pharma Limited
Country of Origin India
Trader N/A
Importer Natco Lifesciences Philippines Inc.
Distributor Natco Lifesciences Philippines Inc.
Application Type Monitored Release (Reconstruction)
Issuance Date 11 November 2022
Expiry Date 31 May 2027